BAX vs PAHC: fair value comparison
Baxter International Inc. and Phibro Animal Health Corporation · Updated 2026-09-12
Both currently screen as undervalued on TickrTrends' Forward Fair Value model. Within Healthcare, PAHC currently sits closer to the top of our discount ranking. PAHC carries the stronger quality grade.
| BAX | PAHC | |
|---|---|---|
| Verdict | Undervalued | Undervalued |
| Last price | $23.80 | $38.26 |
| 12-month range | $16.78–$28.10 | $29.67–$54.52 |
| Sector rank | #54 of 113 Healthcare | #49 of 113 Healthcare |
| Quality grade | F | C |
| Momentum grade | — | C |
| Leverage | High | High |
| Margin trend | Contracting | Expanding |
| Revenue growth | Modest | Strong |
| RSI zone | Oversold | Neutral |
| 50/200-day trend | — | Mixed |
| DCF cross-check | Overvalued | — |
| 52-week position | The upper-middle quarter | The lower-middle quarter |
Full single-stock breakdowns: BAX fair value analysis · PAHC fair value analysis